Initial experience withhirudin andstreptokinase in acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 6 trial
- 1 January 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (1), 7-13
- https://doi.org/10.1016/s0002-9149(99)80517-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Comparison of hirudin and heparin as adjuncts to streptokinase thrombolysis in a canine model of coronary thrombosis.Circulation Research, 1993
- Effect of thrombin inhibition on the dynamics of thrombolysis and on platelet function during thrombolytic therapy.Circulation Research, 1992
- Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.Circulation, 1991
- Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.Circulation, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Enhancing thrombolytic efficacy by means of “front-loaded” administration of tissue plasminogen activatorJournal of the American College of Cardiology, 1989
- Biology of Recombinant Hirudin (CGP 39393): A New Prospect in the Treatment of ThrombosisSeminars in Thrombosis and Hemostasis, 1989
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor.Circulation, 1989